New Delhi metallo-beta-lactamase-1-producing Acinetobacter spp. infection: report of a survivor
Rev. Soc. Bras. Med. Trop
;
49(1): 130-134, Jan.-Feb. 2016. tab
Artículo
en Inglés
| LILACS
| ID: lil-776530
ABSTRACT
Abstract: New Delhi metallo-beta-lactamase-1 (NDM-1) is a bacterial enzyme that renders the bacteria resistant to a variety of beta-lactam antibiotics. A 20-year-old man was hospitalized several times for surgical treatment and complications caused by a right-sided vestibular schwannoma. Although the patient acquired several multidrug-resistant infections, this study focuses on the NDM-1-producing Acinetobacter spp. infection. As it was resistant to all antimicrobials tested, the medical team developed a 20-day regimen of 750mg/day metronidazole, 2,000,000IU/day polymyxin B, and 100mg/day tigecycline. The treatment was effective, and the patient recovered and was discharged from the hospital.
Texto completo:
Disponible
Índice:
LILACS (Américas)
Asunto principal:
Acinetobacter
/
Beta-Lactamasas
/
Infecciones por Acinetobacter
/
Infección Hospitalaria
/
Farmacorresistencia Bacteriana Múltiple
/
Antibacterianos
Límite:
Humanos
/
Masculino
Idioma:
Inglés
Revista:
Rev. Soc. Bras. Med. Trop
Asunto de la revista:
Medicina Tropical
Año:
2016
Tipo del documento:
Artículo
País de afiliación:
Brasil
Institución/País de afiliación:
Universidade do Sul de Santa Catarina/BR
Similares
MEDLINE
...
LILACS
LIS